eleven adult patients with poor-risk non-hodgkin 's lymphoma were treated with high-dose melphalan ( 140 mg/m2 ) or high-dose combination chemotherapy ( bcnu , ara-c , vindesine and melphalan ) followed by autologous bone marrow transplantation .
C0024305
non-hodgkin 's lymphoma
C0007257
bcnu